| 2005 | A Feasibility Study of Adenosine Triphosphate-based Chemotherapy Response Assay (ATP-CRA) as a Chemosensitivity Test for Lung Cancer
| CANCER RESEARCH AND TREATMENT |
| 2011 | A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results. | LUNG CANCER |
| 2003 | Ad-mTERT-Δ19, a Conditional Replication-Competent Adenovirus Driven by the Human Telomerase Promoter, Selectively Replicates in and Elicits Cytopathic Effect in a Cancer Cell-Specific Manner | HUMAN GENE THERAPY |
| 2015 | Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication
| PLOS ONE |
| 2018 | CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
| ONCOTARGET |
| 2001 | CD5와 Cytokeratin 7에 음성이고 Cytokeratin 13에 양성인 흉선 편평상피세포암 1예
| TUBERCULOSIS AND RESPIRATORY DISEASES |
| 2011 | Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2006 | Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect | GENE THERAPY |
| 2018 | Differential Prognostic Impact of Strong PD-L1 Expression and 18F-FDG Uptake in Triple-negative Breast Cancer | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
| 2001 | Efficacy of Pre - and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities
| CANCER RESEARCH AND TREATMENT |
| 2018 | External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence
| Radiation Oncology Journal |
| 2018 | Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
| CANCER RESEARCH AND TREATMENT |
| 2005 | Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 2021 | Genomic landscape of extraordinary responses in metastatic breast cancer
| COMMUNICATIONS BIOLOGY |
| 2006 | Markedly Enhanced Cytolysis by E1B-19kD-Deleted Oncolytic Adenovirus in Combination with Cisplatin | HUMAN GENE THERAPY |
| 2011 | Molecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer | ONCOLOGY |
| 2007 | Multi-disciplinary treatment of a rare pelvic cavity ependymoma
| YONSEI MEDICAL JOURNAL |
| 2012 | Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy
| PLOS ONE |
| 2010 | Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2007 | Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib | JOURNAL OF CLINICAL ONCOLOGY |
| 2013 | S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial
| BMC CANCER |
| 2006 | 난소에 발생한 간양 암종 1예 | Korean Journal of Gynecologic Oncology (부인종양) |
| 2015 | 성장인자수용체-2 양성 유방암 조직에서 표적치료 전후의 성장인자수용체군 발현양상
| Korean Journal of Clinical Oncology (대한임상종양학회지) |
